Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 1.000 | |
3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.559 | |
3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.552 | |
2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.551 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.540 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.540 | |
4at4 | T6E | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.535 | |
4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.532 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.531 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.526 | |
4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.518 | |
4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.517 | |
3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.516 | |
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.516 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.514 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.509 | |
4agc | AXI | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.509 | |
3eta | 351 | Insulin receptor | 2.7.10.1 | 0.508 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.507 | |
3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.507 | |
3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.505 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.503 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.499 | |
4ag8 | AXI | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.498 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.497 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.497 | |
3vw8 | DF6 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.497 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.497 | |
3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.496 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.496 | |
2qu5 | 276 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.495 | |
3e92 | G6A | Mitogen-activated protein kinase 14 | / | 0.492 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.491 | |
2ofv | 242 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.490 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.490 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.490 | |
4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.489 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.489 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.489 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.488 | |
3qri | 919 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.487 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.487 | |
1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.485 | |
1w83 | L11 | Mitogen-activated protein kinase 14 | / | 0.485 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.485 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.484 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.484 | |
1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.482 | |
3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.480 | |
4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.480 | |
2zd1 | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.479 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.479 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.479 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.478 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
3rey | XAC | Adenosine receptor A2a | / | 0.476 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.474 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.474 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.474 | |
2hzi | JIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.472 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.471 | |
3p9t | TCL | Repressor | / | 0.471 | |
2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.470 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.470 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.469 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.469 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.468 | |
3p2o | NAD | Bifunctional protein FolD | / | 0.468 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.468 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.466 | |
3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.466 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.466 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.466 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.464 | |
3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.464 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.464 | |
4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.464 | |
3qak | UKA | Adenosine receptor A2a | / | 0.464 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.463 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
4hvs | 647 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.463 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.462 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.462 | |
3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.462 | |
1jla | TNK | Gag-Pol polyprotein | 2.7.7.49 | 0.461 | |
2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.461 | |
4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.461 | |
4az0 | S61 | Lysosomal protective protein | 3.4.16.5 | 0.461 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.461 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.461 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.461 | |
1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.460 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
1y6b | AAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.460 | |
2e9d | B76 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.460 | |
2vrb | NAP | Triphenylmethane reductase | / | 0.460 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.460 | |
2ze2 | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.460 | |
3h1j | SMA | Cytochrome b | / | 0.460 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.460 | |
1lso | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.459 | |
2yix | YIX | Mitogen-activated protein kinase 14 | / | 0.459 | |
3a1l | 2CC | Cytochrome P450 | / | 0.459 | |
3tam | M06 | Gag-Pol polyprotein | 2.7.7.49 | 0.459 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.459 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.459 | |
5iub | CLR | Adenosine receptor A2a | / | 0.459 | |
1mj3 | HXC | Enoyl-CoA hydratase, mitochondrial | 4.2.1.17 | 0.458 | |
2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
3bx5 | 304 | Mitogen-activated protein kinase 14 | / | 0.458 | |
3t5i | SER_SER_CMT_FAR | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.458 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.457 | |
2xnp | WCX | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.457 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
3d75 | NBB | Pheromone-binding protein ASP1 | / | 0.457 | |
3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.457 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.457 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
1ly4 | COQ | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
1tvr | TB9 | Gag-Pol polyprotein | 2.7.7.49 | 0.456 | |
2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.456 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.456 | |
3g0e | B49 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.456 | |
3of2 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.456 | |
3sfi | 3SF | HTH-type transcriptional regulator EthR | / | 0.456 | |
4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.456 | |
4twp | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.456 | |
5i2h | AGI | O-methyltransferase family 2 | / | 0.456 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.456 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.456 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.455 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.455 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.455 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.455 | |
2bx8 | AZQ | Serum albumin | / | 0.454 | |
2hve | ADP | Nucleoside diphosphate kinase A | 2.7.4.6 | 0.454 | |
3bxx | QUE | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.454 | |
3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.454 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.454 | |
4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.454 | |
4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.454 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.453 | |
3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.453 | |
4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
1bdb | NAD | Cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase | / | 0.452 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.452 | |
3ce3 | 1FN | Hepatocyte growth factor receptor | 2.7.10.1 | 0.452 | |
3cne | FMN | Putative protease I | / | 0.452 | |
3f82 | 353 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.452 | |
3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.452 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.452 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.452 | |
1ozq | PRF | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.451 | |
1vru | AAP | Gag-Pol polyprotein | 2.7.7.49 | 0.451 | |
1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.451 | |
2hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.451 | |
2xkd | T3M | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.451 | |
3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.451 | |
3l70 | JZV | Cytochrome b | / | 0.451 | |
3q0v | LL4 | HTH-type transcriptional regulator EthR | / | 0.451 | |
3v1m | HPK | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase | 3.7.1.8 | 0.451 | |
3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.451 | |
1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.450 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
2w3v | TOP | Dihydrofolate reductase | / | 0.450 | |
3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.450 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.450 | |
3zei | AWH | O-acetylserine sulfhydrylase | / | 0.450 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.450 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.450 | |
4ug2 | NGI | Adenosine receptor A2a | / | 0.450 | |
1s1v | TNK | Gag-Pol polyprotein | 2.7.7.49 | 0.449 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2ham | C33 | Vitamin D3 receptor | / | 0.449 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.449 | |
3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.449 | |
3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.449 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
4qa2 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.449 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.449 | |
1r0e | DFN | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
2ban | 357 | Gag-Pol polyprotein | 2.7.7.49 | 0.448 | |
2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.448 | |
2fzi | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.448 | |
3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.448 | |
4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.448 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.448 | |
3rfm | CFF | Adenosine receptor A2a | / | 0.448 | |
1daj | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.447 | |
1p93 | DEX | Glucocorticoid receptor | / | 0.447 | |
1u80 | C5P | Coenzyme A biosynthesis bifunctional protein CoaBC | 6.3.2.5 | 0.447 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
3b7d | CNI | Glutamate receptor 2 | / | 0.447 | |
3cd2 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.447 | |
3med | 65B | Gag-Pol polyprotein | 2.7.7.49 | 0.447 | |
4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.447 | |
4kd7 | 9DR | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
1lri | CLR | Beta-elicitin cryptogein | / | 0.446 | |
1qvn | FRI | Interleukin-2 | / | 0.446 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.446 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.446 | |
3nwl | NDP | Catalase | 1.11.1.6 | 0.446 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
4cax | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.446 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.446 | |
1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
1nqu | RDL | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.445 | |
1sqv | UHD | Cytochrome b | / | 0.445 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.445 | |
2c31 | ADP | Oxalyl-CoA decarboxylase | 4.1.1.8 | 0.445 | |
2i9p | NAD | 3-hydroxyisobutyrate dehydrogenase, mitochondrial | 1.1.1.31 | 0.445 | |
2yac | 937 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.445 | |
2z3u | CRR | Cytochrome P450 | / | 0.445 | |
2z7h | GG3 | Geranylgeranyl pyrophosphate synthase | / | 0.445 | |
3dko | IHZ | Ephrin type-A receptor 7 | 2.7.10.1 | 0.445 | |
3w2c | N15 | Aurora kinase A | 2.7.11.1 | 0.445 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.445 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4id5 | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.445 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.445 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.445 | |
1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
2acw | UPG | Glycosyltransferase | / | 0.444 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.444 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.444 | |
3fhx | PXL | Pyridoxal kinase | 2.7.1.35 | 0.444 | |
3ipq | 965 | Oxysterols receptor LXR-alpha | / | 0.444 | |
4a9h | TVP | Bromodomain-containing protein 2 | / | 0.444 | |
4azw | ATP | O-antigen chain terminator bifunctional methyltransferase/kinase WbdD | / | 0.444 | |
4oew | 5IO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.444 | |
8cat | NDP | Catalase | 1.11.1.6 | 0.444 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
3iw8 | HIZ | Mitogen-activated protein kinase 14 | / | 0.443 | |
3nax | MP7 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
3t19 | 5MA | Gag-Pol polyprotein | 2.7.7.49 | 0.443 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.443 | |
4afe | GGY | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.443 | |
4elb | 34R | Dihydrofolate reductase | / | 0.443 | |
4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
4g1q | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.443 | |
4ia1 | BIV | Vitamin D3 receptor A | / | 0.443 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.443 | |
5hbs | RTL | Retinol-binding protein 1 | / | 0.443 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
1tl3 | H20 | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
1trg | CB3 | Thymidylate synthase | / | 0.442 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
2wks | CB6 | 3-dehydroquinate dehydratase | 4.2.1.10 | 0.442 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
3dya | PZL | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.442 | |
3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
3t9i | 3T9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.442 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.442 | |
4tqq | UQ1 | Reaction center protein L chain | / | 0.442 | |
1ep4 | S11 | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
1p33 | MTX | Pteridine reductase 1 | 1.5.1.33 | 0.441 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
2hb7 | O1C | Vitamin D3 receptor | / | 0.441 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.441 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
3c4h | DRL | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.441 | |
3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.441 | |
3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.441 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.441 | |
1mb9 | ATP | Carboxyethyl-arginine beta-lactam-synthase | 6.3.3.4 | 0.440 | |
1mc5 | AHE | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.440 | |
1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
3fra | I2H | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
3p6n | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3q5i | ANP | Protein kinase, putative | / | 0.440 | |
3qlh | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
3r6p | A8S | Abscisic acid receptor PYL10 | / | 0.440 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.440 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4cav | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.440 | |
4elf | 35I | Dihydrofolate reductase | / | 0.440 | |
4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.440 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.440 |